1. Home
  2. TWN vs RCEL Comparison

TWN vs RCEL Comparison

Compare TWN & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWN
  • RCEL
  • Stock Information
  • Founded
  • TWN 1986
  • RCEL 2020
  • Country
  • TWN Hong Kong
  • RCEL United States
  • Employees
  • TWN N/A
  • RCEL N/A
  • Industry
  • TWN Trusts Except Educational Religious and Charitable
  • RCEL Medical/Dental Instruments
  • Sector
  • TWN Finance
  • RCEL Health Care
  • Exchange
  • TWN Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • TWN 306.6M
  • RCEL 342.7M
  • IPO Year
  • TWN N/A
  • RCEL N/A
  • Fundamental
  • Price
  • TWN $46.92
  • RCEL $12.25
  • Analyst Decision
  • TWN
  • RCEL Hold
  • Analyst Count
  • TWN 0
  • RCEL 3
  • Target Price
  • TWN N/A
  • RCEL $16.50
  • AVG Volume (30 Days)
  • TWN 20.1K
  • RCEL 92.2K
  • Earning Date
  • TWN 01-01-0001
  • RCEL 11-07-2024
  • Dividend Yield
  • TWN 1.10%
  • RCEL N/A
  • EPS Growth
  • TWN N/A
  • RCEL N/A
  • EPS
  • TWN N/A
  • RCEL N/A
  • Revenue
  • TWN N/A
  • RCEL $60,040,000.00
  • Revenue This Year
  • TWN N/A
  • RCEL $40.34
  • Revenue Next Year
  • TWN N/A
  • RCEL $52.79
  • P/E Ratio
  • TWN N/A
  • RCEL N/A
  • Revenue Growth
  • TWN N/A
  • RCEL 32.24
  • 52 Week Low
  • TWN $25.22
  • RCEL $7.51
  • 52 Week High
  • TWN $41.51
  • RCEL $18.93
  • Technical
  • Relative Strength Index (RSI)
  • TWN 70.80
  • RCEL 50.82
  • Support Level
  • TWN $44.67
  • RCEL $12.19
  • Resistance Level
  • TWN $47.01
  • RCEL $12.75
  • Average True Range (ATR)
  • TWN 1.15
  • RCEL 0.63
  • MACD
  • TWN 0.33
  • RCEL -0.15
  • Stochastic Oscillator
  • TWN 100.00
  • RCEL 30.00

About TWN Taiwan Fund Inc. (The)

Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: